SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-047849
Filing Date
2013-09-05
Accepted
2013-09-05 18:26:46
Documents
2
Period of Report
2013-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd389855.html 4  
1 FORM 4 rrd389855.xml 4 6445
2 POWER OF ATTORNEY rrd350743_397086.htm EX-24. 5465
  Complete submission text file 0001181431-13-047849.txt   13555
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMERSION CORP 801 FOX LN. SAN JOSE CA 95131
Business Address
HODGMAN JOHN (Reporting) CIK: 0001212689 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 131081415